en · de · es · fr · pt
tb-500-notes.peptides8425.com › Guide › Thymosin Beta-4 Fragment Overview — 2026 Update

Thymosin Beta-4 Fragment Overview — 2026 Update

By Editorial Desk · published 2025-09-07 · last reviewed 2025-09-21 · Guide

This is a working overview of thymosin beta-4, written for readers who want more than a one-paragraph summary but less than a textbook.

Reviewed 2025-09-21. Anything still debated is marked as such rather than presented as settled.

Thymosin Beta-4 Fragment Overview

TB-500 refers to a synthetic peptide fragment derived from the actin-binding region of thymosin beta-4, a protein present in most mammalian cells. The full protein contains forty-three amino acids, while the commonly sold fragment is a much shorter acetylated sequence, often cited as LKKTETQ. The fragment retains part of the actin-binding motif but lacks the remainder of the parent protein. Material sold under this name is usually lyophilized powder intended for laboratory research, and it is not a finished pharmaceutical product.

Proposed activity centers on actin sequestration and on the movement of cells during repair processes. In cell culture and animal models, the fragment has been associated with migration, tube formation, and tissue remodeling. These observations are frequently described as preliminary, because most published work uses rodent or in vitro systems rather than controlled human trials. Whether the short fragment reproduces the effects of the full protein remains an open question, and the relationship between dose, route, and measured outcome is not well characterized.

Handling, Storage, and Analysis

Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.

Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.

Tb-500 at a glance

PropertyValueNotes
AppearanceWhite to off-white powderLyophilized solid as supplied
Water solubilitySolubleDissolves in aqueous media
Typical storage temperature-20 °CDry powder, desiccated, protected from light
Typical analytical methodRP-HPLC with mass spectrometryPurity from peak area; mass for identity
Common synonymsTβ4 fragment; thymosin beta-4 fragmentNaming varies by supplier and catalogue

Identity and Research Background

TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.

Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.

Related pages on this site

Handling, Storage, and Quality Control

Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.

Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.

Reference notes

== Epitope tags == Epitopes are often used in proteomics and the study of other gene products. Using recombinant DNA techniques genetic sequences coding for epitopes that are recognized by common antibodies can be fused to the gene. Following synthesis, the resulting epitope tag allows the antibody to find the protein or other gene product enabling lab techniques for localisation, purification, and further molecular characterization including identifying the protein's binding partners. Common epitopes used for this purpose are Myc-tag, HA-tag, FLAG-tag, GST-tag, 6xHis, V5-tag and OLLAS. An epitope tag was first described by Munro and Pelham to detect and track proteins in 1984. Tags were quickly adapted for purifying proteins and to detect, pull down, and clone interaction partners of proteins. These tags were originally referred to as "peptide tag", "epitope insertion", "marker sequence", and "epitope addition", until "epitope tag" was coined and popularized. Peptides can also be bound by proteins that form covalent bonds to the peptide, allowing irreversible immobilisation. These strategies have also been successfully applied to the development of "epitope-focused" vaccine design.

=== Schizophrenic behavior of UCST-LCST diblock copolymers === A more complex scenario can be found in the case of diblock copolymers that feature two orthogonally thermo-responsive blocks, i.e., an UCST and an LCST-type block. By applying a temperature stimulus, the individual polymer blocks show different phase transitions, e.g. by increasing the temperature, the UCST-type block features an insoluble-soluble transition, while the LCST-type block undergoes a soluble-insoluble transition. The order of the individual phase transitions depends on the relative positions of the UCST and LCST. Thus, upon temperature change the roles of the soluble and insoluble polymer blocks are reversed and this structural inversion is typically called 'schizophrenic' in the literature. Besides the fundamental interest in the mechanism of this behavior, such block copolymers have been proposed for application in smart emulsification, drug delivery, and rheology control. Schizophrenic diblock copolymer have also been applied as thin films for potential use as sensors, smart coatings or nanoswitches, and soft robotics.

== Theory == The formation of a complex between a metal ion, M, and a ligand, L, is in fact usually a substitution reaction. For example, in aqueous solutions, metal ions will be present as aqua ions, so the reaction for the formation of the first complex could be written as

Sources: en.wikipedia.org

Reference notes

==== European Union ==== Danish pharmaceutical company Lundbeck has licensed nalmefene from Biotie Therapies and performed clinical trials with nalmefene for treatment of alcohol dependence. In 2011, they submitted an application for their medication named Selincro to the European Medicines Agency. The medication was authorized for use in the EU in March 2013. and in October 2013, Scotland became the first country in the EU to prescribe the drug for alcohol dependence. England followed Scotland by offering the medication as a treatment for problem drinking in October 2014. In November 2014, nalmefene was approved as a possible treatment supplied by Britain's National Health Service (NHS) for reducing alcohol consumption in people with alcohol dependence.

Improving metabolism (improving insulin sensitivity, inhibiting de novo lipogenesis, or increasing fatty acid oxidation). Metabolic modulators tested in MASH include glucagon-like peptide-1 receptor agonists (GLP-1 agonists), GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) or glucagon co-agonists and thyromimetics. Some of these drugs may treat MASFLD by significantly reducing body weight. Reducing inflammation, for example reducing oxidative stress and hepatocyte death. These drugs, such as chemokine antagonists, anti-apoptotics, vascular adhesion protein-1 inhibitors, and c-Jun N-terminal kinase inhibitors, have not shown benefit. "Gut-liver axis targets" that either change a person's microbiome, or act on bile acids Anti-fibrotic drugs, such as fibroblast growth factor analogues, which have largely not met their endpoints Other treatments such as farnesoid X receptor (FXR) agonists, peroxisome proliferator-activated receptor (PPAR) agonists, and ASK1 (apoptosis signal-regulating kinase 1) inhibitors may improve MASFLD by multiple mechanisms simultaneously.

=== Bird decline === Besides the effects of direct consumption of insecticides, populations of insectivorous birds decline due to the collapse of their prey populations. Spraying of especially wheat and corn in Europe is believed to have caused an 80 per cent decline in flying insects, which in turn has reduced local bird populations by one to two thirds.

Sources: en.wikipedia.org

Reference notes

== Structure and functions of procollagen galactosyltransferase 1 == Procollagen galactosyltransferase 1 (GT251), encoded by the COLGALT1 gene, plays a crucial role in lysyl O-linked glycosylation and the maturation of collagen. GT251 consists of two galactosyltransferase domains (GalT-N and GalT-C) and is stabilized in a dimeric form. The GT251 dimer can further associate with LH3 (encoded by PLOD3) to form a heterotetrameric complex, known as the KOGG complex (Lysyl Hydroxylation-Galactosylation-Glucosylation complex). Within this complex, three key enzymatic reactions in lysine O-linked glycosylation are coordinately catalyzed by LH3 and GT251, ensuring proper collagen modification and structural integrity.

Their father, Nathan Rothschild, 1st Baron Rothschild, head of the English branch of the family, had a guarded attitude towards Zionism, but he died in March 1915 and his title was inherited by Walter. Prior to the declaration, about 8,000 of Britain's 300,000 Jews belonged to a Zionist organisation. Globally, as of 1913 – the latest known date prior to the declaration – the equivalent figure was approximately 1%.

In the 19th century, it was common to give children a mixture of sulfur and treacle as a remedy. The sulfur in it was meant to act as a spring tonic and a laxative. Reportedly foul-tasting, "brimstone and treacle" was considered by many an unpleasant childhood experience, and it is mentioned as such in a number of cultural references, including Mary Poppins, the works of Charles Dickens, and the controversial 1976 British play of the same name. Madam C. J. Walker, who became the first female millionnaire by selling hair products for Black women in the early 1900s, notably used sulfur as an ingredient in her products. Sulfur was also used in fumigations against the plague. In the early 20th century, during the Third Plague Pandemic, devices like the Clayton machine, used in harbors across the world, or the Sulfurozador in Latin America, were used to spread sulfur dioxide gas to kill insects, rats and pathogens.

The Aviation and Transportation Security Act made the federal government, rather than airports, responsible for airport security. The law created the Transportation Security Administration to inspect passengers and luggage, causing long delays and concern over passenger privacy. After suspected abuses of the USA Patriot Act were brought to light in June 2013 with articles about the collection of American call records by the NSA and the PRISM program, Representative Jim Sensenbrenner (of Wisconsin), who introduced the Patriot Act in 2001, said that the NSA overstepped its bounds. Criticism of the war on terror has focused on its morality, efficiency, and cost. According to a 2021 report by the Costs of War Project, the several post-9/11 wars participated in by the United States in its war on terror have caused the displacement, conservatively calculated, of 38 million people in Afghanistan, Pakistan, Iraq, Libya, Syria, Yemen, Somalia, and the Philippines. They estimated these wars caused the deaths of 897,000 to 929,000 people directly and cost US$8 trillion. In a 2023 report, the Costs of War Project estimated that there have been between 3.6 and 3.7 million indirect deaths in the post-9/11 war zones, with the total death toll being 4.5 to 4.6 million. The report defined post-9/11 war zones as conflicts that included significant United States counter-terrorism operations since 9/11, which in addition to the wars in Iraq, Afghanistan and Pakistan, also includes the civil wars in Syria, Yemen, Libya and Somalia.

Sources: en.wikipedia.org

Frequently asked questions

What is TB-500?

TB-500 is a name used for a short synthetic peptide fragment taken from the actin-binding region of thymosin beta-4. Material sold under this label is usually a lyophilized powder supplied for laboratory research rather than a licensed medicine. The commonly cited sequence is LKKTETQ.

How does it differ from full thymosin beta-4?

The parent protein contains forty-three amino acids, while the fragment carries only a short motif from one region. The fragment can interact with actin in vitro, but it does not include the rest of the protein structure. Whether the shorter molecule behaves the same way in living systems is not settled.

Is human evidence available?

Published controlled human studies are scarce, and most activity reports come from cell culture or animal models. Reviews often describe the evidence base as limited and methodologically uneven. Open questions include the relationship between route, dose, and measured outcomes.

How is the material stored?

The lyophilised powder is typically held at -20 C or lower in a dry, dark place. Reconstituted solutions are aliquoted and frozen to avoid repeated freeze-thaw cycles.

Network